281 related articles for article (PubMed ID: 17533390)
1. Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma.
Lau YS; Adamopoulos IE; Sabokbar A; Giele H; Gibbons CL; Athanasou NA
Br J Cancer; 2007 Jun; 96(11):1716-22. PubMed ID: 17533390
[TBL] [Abstract][Full Text] [Related]
2. Malignant melanoma and bone resorption.
Lau YS; Sabokbar A; Giele H; Cerundolo V; Hofstetter W; Athanasou NA
Br J Cancer; 2006 May; 94(10):1496-503. PubMed ID: 16641914
[TBL] [Abstract][Full Text] [Related]
3. Ewing sarcoma cells express RANKL and support osteoclastogenesis.
Taylor R; Knowles HJ; Athanasou NA
J Pathol; 2011 Oct; 225(2):195-202. PubMed ID: 21547906
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid macrophages are capable of osteoclast formation and resorption.
Adamopoulos IE; Sabokbar A; Wordsworth BP; Carr A; Ferguson DJ; Athanasou NA
J Pathol; 2006 Jan; 208(1):35-43. PubMed ID: 16278818
[TBL] [Abstract][Full Text] [Related]
5. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
Sabokbar A; Kudo O; Athanasou NA
J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
[TBL] [Abstract][Full Text] [Related]
6. RANKL-dependent and RANKL-independent mechanisms of macrophage-osteoclast differentiation in breast cancer.
Lau YS; Danks L; Sun SG; Fox S; Sabokbar A; Harris A; Athanasou NA
Breast Cancer Res Treat; 2007 Sep; 105(1):7-16. PubMed ID: 17151927
[TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Yang TT; Sabokbar A; Gibbons CL; Athanasou NA
J Bone Joint Surg Br; 2002 Apr; 84(3):452-6. PubMed ID: 12002510
[TBL] [Abstract][Full Text] [Related]
8. Osteoclast formation and function in pigmented villonodular synovitis.
Taylor R; Kashima TG; Knowles H; Gibbons CL; Whitwell D; Athanasou NA
J Pathol; 2011 Sep; 225(1):151-6. PubMed ID: 21706481
[TBL] [Abstract][Full Text] [Related]
9. VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.
Guan H; Zhou Z; Cao Y; Duan X; Kleinerman ES
Oncol Res; 2009; 18(2-3):117-25. PubMed ID: 20066901
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
[TBL] [Abstract][Full Text] [Related]
11. Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages.
Itonaga I; Sabokbar A; Murray DW; Athanasou NA
Ann Rheum Dis; 2000 Jan; 59(1):26-31. PubMed ID: 10627423
[TBL] [Abstract][Full Text] [Related]
12. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
Taylor RM; Kashima TG; Knowles HJ; Athanasou NA
Lab Invest; 2012 Oct; 92(10):1398-406. PubMed ID: 22906984
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction.
Kobayashi K; Takahashi N; Jimi E; Udagawa N; Takami M; Kotake S; Nakagawa N; Kinosaki M; Yamaguchi K; Shima N; Yasuda H; Morinaga T; Higashio K; Martin TJ; Suda T
J Exp Med; 2000 Jan; 191(2):275-86. PubMed ID: 10637272
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue.
Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N
Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456
[TBL] [Abstract][Full Text] [Related]
15. CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
Taylor RM; Kashima TG; Hemingway FK; Dongre A; Knowles HJ; Athanasou NA
Lab Invest; 2012 Apr; 92(4):600-5. PubMed ID: 22330339
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis.
Hirayama T; Danks L; Sabokbar A; Athanasou NA
Rheumatology (Oxford); 2002 Nov; 41(11):1232-9. PubMed ID: 12421995
[TBL] [Abstract][Full Text] [Related]
17. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation.
Quinn JM; Horwood NJ; Elliott J; Gillespie MT; Martin TJ
J Bone Miner Res; 2000 Aug; 15(8):1459-66. PubMed ID: 10934644
[TBL] [Abstract][Full Text] [Related]
18. Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells.
Quinn JM; McGee JO; Athanasou NA
J Pathol; 1998 Jan; 184(1):31-6. PubMed ID: 9582524
[TBL] [Abstract][Full Text] [Related]
19. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening.
Sabokbar A; Itonaga I; Sun SG; Kudo O; Athanasou NA
J Orthop Res; 2005 May; 23(3):511-9. PubMed ID: 15885469
[TBL] [Abstract][Full Text] [Related]
20. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand.
Udagawa N; Takahashi N; Jimi E; Matsuzaki K; Tsurukai T; Itoh K; Nakagawa N; Yasuda H; Goto M; Tsuda E; Higashio K; Gillespie MT; Martin TJ; Suda T
Bone; 1999 Nov; 25(5):517-23. PubMed ID: 10574571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]